The Valley Desk

NCT03029143 · Interventional trial

Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis

Overall registry status Completed

Phase 4

Conditions Colitis, Ulcerative

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov